The Big Data in the Healthcare & Pharmaceutical Industry: 2017 – 2030 – Opportunities, Challenges, Strategies & Forecasts report presents an in-depth assessment of Big Data in the healthcare and pharmaceutical industry including key market drivers, challenges, investment potential, application areas, use cases, future roadmap, value chain, case studies, vendor profiles and strategies.
The Big Data in the Healthcare & Pharmaceutical Market Report also presents market size forecasts for Big Data hardware, software and professional services investments from 2017 through to 2030. The forecasts are segmented for 8 horizontal sub markets, 5 application areas, 36 use cases, 6 regions and 35 countries.
Get inside view of the Report with SAMPLE Pages @ http://orbisresearch.com/contacts/request-sample/374563?utm_source=sru
Big Data originally emerged as a term to describe datasets whose size is beyond the ability of traditional databases to capture, store, manage and analyze. However, the scope of the term has significantly expanded over the years. Big Data not only refers to the data itself but also a set of technologies that capture, store, manage and analyze large and variable collections of data, to solve complex problems.
The following companies and organizations have been reviewed, discussed or mentioned in the report:
ASTM (American Society for Testing and Materials), DXC Technology, GNS Healthcare, Mayo Clinic, Luminoso Technologies, ODCA (Open Data Center Alliance), Recorded Future, Red Hat, SAP, Toshiba Corporation, Strategy Companion Corporation, Tableau Software
Amid the proliferation of real-time and historical data from sources such as connected devices, web, social media, sensors, log files and transactional applications, Big Data is rapidly gaining traction from a diverse range of vertical sectors. The healthcare and pharmaceutical industry is no exception to this trend, where Big Data has found a host of applications ranging from drug discovery and precision medicine to clinical decision support and population health management.
The Report estimates that Big Data investments in the healthcare and pharmaceutical industry will account for nearly $4 Billion in 2017 alone. Led by a plethora of business opportunities for healthcare providers, insurers, payers, government agencies, pharmaceutical companies and other stakeholders, these investments are further expected to grow at a CAGR of more than 15% over the next three years.
Topics Covered in the Report:
Big Data ecosystem
Market drivers and barriers
Enabling technologies, standardisation and regulatory initiatives
Big Data analytics and implementation models
Business case, application areas and use cases in the healthcare and pharmaceutical industry
34 case studies of Big Data investments by healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders
Company profiles and strategies of over 240 Big Data vendors
Strategic recommendations for Big Data vendors, and healthcare and pharmaceutical industry stakeholders
Regional Markets Covered in this Report includes:
Latin & Central America
Middle East & Africa
Key Questions Answered:
How big is the Big Data opportunity in the healthcare and pharmaceutical industry?
How is the market evolving by segment and region?
What will the market size be in 2020 and at what rate will it grow?
What trends, challenges and barriers are influencing its growth?
Who are the key Big Data software, hardware and services vendors and what are their strategies?
How much are healthcare providers, insurers, payers, pharmaceutical companies and other stakeholders investing in Big Data?
What opportunities exist for Big Data analytics in the healthcare and pharmaceutical industry?
Which countries, application areas and use cases will see the highest percentage of Big Data investments in the healthcare and pharmaceutical industry?
Request to Purchase the Report @ http://orbisresearch.com/contact/purchase/374563?utm_source=sru
In 2017, Big Data vendors will pocket nearly $4 Billion from hardware, software and professional services revenues in the healthcare and pharmaceutical industry. These investments are further expected to grow at a CAGR of more than 15% over the next three years, eventually accounting for over $5.8 Billion by the end of 2020.
Through the use of Big Data technologies, hospitals and other healthcare facilities have been able to achieve cost reductions of more than 10%, improvements in outcomes by as much as 20% for certain conditions, growth in revenue by 30%, and increase in patient access to services by more than 35%.
Big Data technologies are playing a pivotal role in accelerating the transition towards accountable and value-based care models, by enabling the continuous collection, consolidation and analysis of clinical and operational data from healthcare facilities and other available data sources.
Table of Content:
1 Chapter 1: Introduction 24
2 Chapter 2: An Overview of Big Data 38
3 Chapter 3: Big Data Analytics 51
4 Chapter 4: Business Case & Applications in the Healthcare & Pharmaceutical Industry 59
5 Chapter 5: Healthcare & Pharmaceutical Industry Case Studies 89
6 Chapter 6: Future Roadmap & Value Chain 140
7 Chapter 7: Standardization & Regulatory Initiatives 147
8 Chapter 8: Market Analysis & Forecasts 175
9 Chapter 9: Vendor Landscape 232
10 Chapter 10: Conclusion & Strategic Recommendations 489
The report comes with an associated Excel datasheet suite covering quantitative data from all numeric forecasts presented in the report.
Request to Enquire before Purchasing the Report @ http://orbisresearch.com/contacts/enquiry-before-buying/374563?utm_source=sru
Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.
Senior Manager – Client Engagements
4144N Central Expressway,
Suite 600, Dallas,
Texas – 75204, U.S.A.
Phone No.: +1 (214) 884-6817; +9164101019